| Nome |
# |
|
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study, file e39773b6-3111-35a3-e053-3a05fe0aac26
|
540
|
|
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer, file 3487cb19-2792-4e85-995a-8ecc6b2e815a
|
81
|
|
Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma., file e39773b8-a359-35a3-e053-3a05fe0aac26
|
73
|
|
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool, file 7116521d-dd0b-49a3-9f33-d25545ad00d8
|
71
|
|
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid, file bacfed04-02e4-4603-8b55-6534a52426b5
|
64
|
|
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study, file e39773b8-1347-35a3-e053-3a05fe0aac26
|
63
|
|
Corrigendum to Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis [Int. J. Surg., 18, (2015), 196-204] Doi: 10.1016/j.ijsu.2015.04.083, file a5b930db-65e3-47a3-aa9f-7d7acc5d5cbd
|
50
|
|
The societal burden of chronic liver diseases: Results from the COME study, file e39773b7-8de8-35a3-e053-3a05fe0aac26
|
50
|
|
The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): A post-hoc between-sex analysis, file e39773b7-a287-35a3-e053-3a05fe0aac26
|
47
|
|
The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management, file ed8feceb-5621-4ab4-8f51-fa6d8e7925e2
|
45
|
|
Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study, file e39773b8-90a1-35a3-e053-3a05fe0aac26
|
34
|
|
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination, file a2f70cfe-f84c-44fc-81c3-69409c4246d3
|
31
|
|
COVID-19: role of resilience on the psychological impact of lockdown in liver transplant transitional candidates and recipients
COVID-19: ruolo della resilienza sull’impatto psicologico del lockdown nei candidati e nei riceventi del trapianto di fegato (adolescenti-giovani adulti), file d29f02d7-5172-45d9-a82b-9ee044389db2
|
31
|
|
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients, file 309f4721-ea7a-4f92-92e5-52671ae8cc36
|
26
|
|
Characterization of compliance phenotypes in COVID-19 acute respiratory distress syndrome, file 3c86cd60-9dfd-43b5-93ec-dd4ed7b10c1e
|
22
|
|
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antivirals, file d3954ccb-1024-432c-bdc2-76cfd3ef2d96
|
21
|
|
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study., file e39773b8-94f0-35a3-e053-3a05fe0aac26
|
16
|
|
Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA), file 9088b88a-2d3a-4e69-aecf-996239662d03
|
10
|
|
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination, file afc1d496-6a5d-4f90-8bd6-03165dcc6f3c
|
7
|
|
Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis, file c049f634-9707-4ca9-b4c1-0560788c3733
|
7
|
|
Corrigendum to Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis [Int. J. Surg., 18, (2015), 196-204] Doi: 10.1016/j.ijsu.2015.04.083, file 2595e8dc-3db6-4ac7-8e9d-791c40ffdc29
|
5
|
|
Verso una modalità condivisa di profilassi post–olt con immunoglobuline antiepatite B, file 729fd9e9-8f01-49ed-a7ec-e08f2d8e49a5
|
4
|
|
Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination, file c5dce129-882b-4199-80fb-bf02126331f7
|
4
|
|
One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity, file c5f035b8-2fe7-4d3c-a85b-d93edb80acb3
|
4
|
|
La gestione nel presente dell’epatite cronica B per risultati a lungo termine, file e39773b8-86cb-35a3-e053-3a05fe0aac26
|
4
|
|
COMBINED "EN BLOC" LIVER-PANCREAS TRANSPLANTATION USING WHOLE SIZE AND SPLIT LIVER GRAFTS, file e39773b8-1222-35a3-e053-3a05fe0aac26
|
3
|
|
Strategie terapeutiche nella gestione del paziente con epatite cronica HCV-correlata, file e39773b8-a629-35a3-e053-3a05fe0aac26
|
3
|
|
Histology predicts cirrhotic evolution of post transplant hepatitis C, file e39773b8-6356-35a3-e053-3a05fe0aac26
|
2
|
|
Human hepatocytes differ from rat hepatocytes in their sensitivity to anoxia-reoxygenation injury, file e39773b8-6523-35a3-e053-3a05fe0aac26
|
2
|
|
Prophylaxis and treatment of hepatitis B in immunocompromised patients, file e39773b8-7890-35a3-e053-3a05fe0aac26
|
2
|
|
Anthropopmetric measurements, hand grip, strenght and bioelectrical impedance analysis in assessment of the nutritional status of ascitic patients with non-alcoholic liver cirrhosis awaiting for liver transplantation, file e39773b8-7d5e-35a3-e053-3a05fe0aac26
|
2
|
|
Use of anti-HCV positive grafts in liver transplantation, file e39773b8-86cc-35a3-e053-3a05fe0aac26
|
2
|
|
Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease, file e39773b8-86d0-35a3-e053-3a05fe0aac26
|
2
|
|
Histological features after liver transplantation in alcoholic cirrhotics, file e39773b8-90a0-35a3-e053-3a05fe0aac26
|
2
|
|
Iterferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation., file e39773b8-a189-35a3-e053-3a05fe0aac26
|
2
|
|
Percorso diagnostico terapeutico assistenziale “la gestione del paziente affetto da epatopatia cronica". Aggiornamento: febbraio 2018, file e39773b8-a62a-35a3-e053-3a05fe0aac26
|
2
|
|
Natural alpha-IFN in HCV recurrence after liver transplantation, file e39773b8-aa85-35a3-e053-3a05fe0aac26
|
2
|
|
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome, file c9e89222-bfcb-44f9-a576-9854536478cb
|
1
|
|
AN UPDATED PROGNOSTIC MODEL FOR HCC PROGRESSION APPLICABLE TO ORGAN ALLOCATION CORRECTS THE OVERESTIMATION GENERATED BY THE CURRENT UNOS/MELD EXCEPTION, file e39773b7-e6d0-35a3-e053-3a05fe0aac26
|
1
|
|
LIVER TRANSPLANTATION IN HIV-POSITIVE PATIENTS: THE INITIAL EXPERIENCE, file e39773b7-e73a-35a3-e053-3a05fe0aac26
|
1
|
|
Genotype 2 and 3 Reccurent Hepatitis C after Liver Transplantation: Excellent Results with Suboptimal Doses of Antiviral Therapy, file e39773b7-e92f-35a3-e053-3a05fe0aac26
|
1
|
|
GENOTYPE 2 AND 3 RECCURENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EXCELLENT RESULTS WITH SUBOPTIMAL DOSES OF ANTIVIRAL THERAPY, file e39773b7-e934-35a3-e053-3a05fe0aac26
|
1
|
|
Liver transplantation in patients with non-neoplastic portal vein thrombosis: 20 years of experience in a single center, file e39773b7-ed4a-35a3-e053-3a05fe0aac26
|
1
|
|
THE BENEFIT OF ANTIVIRAL THERAPY ON FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION (LT): AN ITALIAN MULTICENTER STUDY, file e39773b8-1052-35a3-e053-3a05fe0aac26
|
1
|
|
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA, file e39773b8-1229-35a3-e053-3a05fe0aac26
|
1
|
|
ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION: THE IMPACT ON FIBROSIS PROGRESSION, file e39773b8-2138-35a3-e053-3a05fe0aac26
|
1
|
|
DONORS AND RECIPIENTS CHARACTERISTICS ASSOCIATED WITH LIVER GRAFT FAILURE IN CHIRROTIC RECIPIENTS: A EUROPEAN SINGLE CENTRE EXPERIENCE, file e39773b8-2485-35a3-e053-3a05fe0aac26
|
1
|
|
Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma, file e39773b8-651b-35a3-e053-3a05fe0aac26
|
1
|
|
Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study, file e39773b8-651d-35a3-e053-3a05fe0aac26
|
1
|
|
Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1, file e39773b8-6520-35a3-e053-3a05fe0aac26
|
1
|
|
Biliary complications of liver transplantation, file e39773b8-66fd-35a3-e053-3a05fe0aac26
|
1
|
|
FK 506 modulates D-galactosamine-induced hepatitis in rats, file e39773b8-6704-35a3-e053-3a05fe0aac26
|
1
|
|
Management of hepatitis C virus infection recurrence after liver transplantation: an overview, file e39773b8-7901-35a3-e053-3a05fe0aac26
|
1
|
|
Folate in gastrointestinal health and disease, file e39773b8-7d5b-35a3-e053-3a05fe0aac26
|
1
|
|
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma, file e39773b8-7d5c-35a3-e053-3a05fe0aac26
|
1
|
|
Infections in acute liver failure, file e39773b8-7d60-35a3-e053-3a05fe0aac26
|
1
|
|
Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation, file e39773b8-7d61-35a3-e053-3a05fe0aac26
|
1
|
|
Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness., file e39773b8-7d63-35a3-e053-3a05fe0aac26
|
1
|
|
Liver transplantation for subfulminant hepatitis, file e39773b8-86cd-35a3-e053-3a05fe0aac26
|
1
|
|
Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features, file e39773b8-909d-35a3-e053-3a05fe0aac26
|
1
|
|
Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF), file e39773b8-90a2-35a3-e053-3a05fe0aac26
|
1
|
|
La cronicità nel passaggio dall’età pediatrica a quella adulta: come accompagnare la transizione, file e39773b8-90a3-35a3-e053-3a05fe0aac26
|
1
|
|
Incidence and clinical predictors of primary opportunistic deep cutaneous mycoses in solid organ transplant recipients: A multicenter cohort study, file e39773b8-a18b-35a3-e053-3a05fe0aac26
|
1
|
|
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features, file e39773b8-a2e4-35a3-e053-3a05fe0aac26
|
1
|
|
Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib, file e39773b8-a354-35a3-e053-3a05fe0aac26
|
1
|
|
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders, file e39773b8-a355-35a3-e053-3a05fe0aac26
|
1
|
|
Risk of hepatocellular carcinoma in alcoholic cirrhosis, file e39773b8-a35e-35a3-e053-3a05fe0aac26
|
1
|
|
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C, file e39773b8-a361-35a3-e053-3a05fe0aac26
|
1
|
|
Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments, file f54709e5-a00d-40e9-84a8-4ca1b3f7029d
|
1
|
| Totale |
1.368 |
